Eiken Chemical Co., Ltd. manufactures and sells clinical diagnostics and equipment in Japan. The company is involved in developing clinical diagnostic aids to various aspects of contemporary medicine, including biochemical, immunological, serological, dry chemical diagnosis, and automatic analyzers. It also develops and supplies OC-SENSOR, an automated immunochemical fecal test for detecting gastrointestinal bleeding associated with disorders, such as colorectal cancer, polyps, and diverticulitis. In addition, the company offers real-time turbidi meters, and homeothermal equipment; amplification kits and fluorescence detection reagents for research use; and detection kits. Further, it manufactures a range of products that are used in the field of microbiology; and provides other products comprising immunological and serological reagents. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was founded in 1939 and is headquartered in Tokyo, Japan.
P/B ratio for Eiken Chemical Co., Ltd. (4549.T)
P/B ratio as of 2023: 1.59
According to Eiken Chemical Co., Ltd.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.59. At the end of 2022 the company had a P/B ratio of 1.17.
P/B ratio history for Eiken Chemical Co., Ltd. from 2004 to 2023
P/B ratio at the end of each year
| Year | P/B ratio |
|---|---|
| 2023 | 1.59 |
| 2022 | 1.17 |
| 2021 | 1.39 |
| 2020 | 1.92 |
| 2019 | 1.95 |
| 2018 | 2.75 |
| 2017 | 3.02 |
| 2016 | 1.85 |
| 2015 | 1.53 |
| 2014 | 1.35 |
| 2013 | 1.34 |
| 2012 | 1.00 |
| 2011 | 0.94 |
| 2010 | 0.86 |
| 2009 | 0.88 |
| 2008 | 0.66 |
| 2007 | 0.90 |
| 2006 | 1.73 |
| 2005 | 1.30 |
| 2004 | 1.57 |